469 related items for PubMed ID: 21810762
1. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.
Nephrol Dial Transplant; 2012 Mar; 27(3):1083-9. PubMed ID: 21810762
[Abstract] [Full Text] [Related]
2. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
Huang J, Du J, Wang S, Xiao L, Zhao X.
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058
[Abstract] [Full Text] [Related]
3. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J.
Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
[Abstract] [Full Text] [Related]
4. Novel use of rituximab for steroid-dependent nephrotic syndrome in children.
Kimata T, Hasui M, Kino J, Kitao T, Yamanouchi S, Tsuji S, Kaneko K.
Am J Nephrol; 2013 May; 38(6):483-8. PubMed ID: 24296765
[Abstract] [Full Text] [Related]
5. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
6. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD, MacLeod R, Rigby E, Clark AG.
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[Abstract] [Full Text] [Related]
7. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
8. Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.
Tellier S, Brochard K, Garnier A, Bandin F, Llanas B, Guigonis V, Cailliez M, Pietrement C, Dunand O, Nathanson S, Bertholet-Thomas A, Ichay L, Decramer S.
Pediatr Nephrol; 2013 Jun; 28(6):911-8. PubMed ID: 23340857
[Abstract] [Full Text] [Related]
9. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group.
Lancet; 2014 Oct 04; 384(9950):1273-81. PubMed ID: 24965823
[Abstract] [Full Text] [Related]
10. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.
Pediatr Nephrol; 2008 Aug 04; 23(8):1269-79. PubMed ID: 18465150
[Abstract] [Full Text] [Related]
11. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.
Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.
Pediatr Nephrol; 2011 Oct 04; 26(10):1823-8. PubMed ID: 21556716
[Abstract] [Full Text] [Related]
12. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
[Abstract] [Full Text] [Related]
13. Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
Kemper MJ, Kuwertz-Broeking E, Bulla M, Mueller-Wiefel DE, Neuhaus TJ.
Nephrol Dial Transplant; 2004 May 01; 19(5):1136-41. PubMed ID: 14993510
[Abstract] [Full Text] [Related]
14. [Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab].
Kamei K, Okada M, Miyazono A, Sato M, Fujimaru T, Ogura M, Ito S.
Nihon Jinzo Gakkai Shi; 2013 May 01; 55(5):947-55. PubMed ID: 23980480
[Abstract] [Full Text] [Related]
15. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K.
Pediatr Nephrol; 2013 Feb 01; 28(2):257-64. PubMed ID: 23052656
[Abstract] [Full Text] [Related]
16. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
Kamei K, Ogura M, Sato M, Sako M, Iijima K, Ito S.
Pediatr Nephrol; 2016 Jan 01; 31(1):89-95. PubMed ID: 26341251
[Abstract] [Full Text] [Related]
17. Rituximab in steroid-dependent nephrotic syndrome.
El Koumi M.
Iran J Kidney Dis; 2013 Nov 01; 7(6):502-6. PubMed ID: 24241100
[Abstract] [Full Text] [Related]
18. Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K.
Pediatr Nephrol; 2010 Mar 01; 25(3):539-44. PubMed ID: 20049616
[Abstract] [Full Text] [Related]
19. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.
Clin Nephrol; 2014 Mar 01; 81(3):166-73. PubMed ID: 24361057
[Abstract] [Full Text] [Related]
20. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr 01; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
